Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)
 
 • Company Description   
Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark.

Number of Employees: 335

 
 • Price / Volume Information   
Yesterday's Closing Price: $69.02 Daily Weekly Monthly
20 Day Moving Average: 231 shares
Shares Outstanding: 71.02 (millions)
Market Capitalization: $4,902.08 (millions)
Beta: 0.73
52 Week High: $136.76
52 Week Low: $49.98
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 25.46% 23.25%
12 Week 15.03% 4.49%
Year To Date -32.57% -39.80%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Sydmarken 11 Soborg
-
Copenhagen,G7 2860
DNK
ph: 45-8877-3600
fax: 45-8877-3898
investors@zealandpharma.com http://www.zealandpharma.com
 
 • General Corporate Information   
Officers
Adam Steensberg - Chief Executive Officer and President
Martin Nicklasson - Chairman of the Board of Directors
Ivan Moller - Executive Vice President;Chief Operating Officer
Henriette Wennicke - Executive Vice President and Chief Financial Offic
Bernadette Connaughton - Director

Peer Information
Zealand Pharma A/S (CORR.)
Zealand Pharma A/S (RSPI)
Zealand Pharma A/S (CGXP)
Zealand Pharma A/S (BGEN)
Zealand Pharma A/S (GTBP)
Zealand Pharma A/S (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: K9898X127
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/06/25
Share - Related Items
Shares Outstanding: 71.02
Most Recent Split Date: (:1)
Beta: 0.73
Market Capitalization: $4,902.08 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.23 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $13.48 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 5.12
Trailing 12 Months: 4.85
PEG Ratio: -
Price Ratios
Price/Book: 4.18
Price/Cash Flow: -
Price / Sales: 3.54
EPS Growth
vs. Year Ago Period: 2,497.01%
vs. Previous Quarter: 2,497.01%
Sales Growth
vs. Year Ago Period: 27,961.12%
vs. Previous Quarter: 121,022.70%
ROE
06/30/25 - 67.06
03/31/25 - -13.40
12/31/24 - -14.46
ROA
06/30/25 - 61.12
03/31/25 - -12.28
12/31/24 - -13.07
Current Ratio
06/30/25 - 15.09
03/31/25 - 25.10
12/31/24 - 21.14
Quick Ratio
06/30/25 - -
03/31/25 - 25.07
12/31/24 - 21.11
Operating Margin
06/30/25 - 73.90
03/31/25 - -2,127.09
12/31/24 - -1,725.03
Net Margin
06/30/25 - 73.90
03/31/25 - -2,127.09
12/31/24 - -1,725.03
Pre-Tax Margin
06/30/25 - 79.78
03/31/25 - -2,136.10
12/31/24 - -1,728.27
Book Value
06/30/25 - -
03/31/25 - 16.51
12/31/24 - 17.59
Inventory Turnover
06/30/25 - -0.65
03/31/25 - 0.64
12/31/24 - 2.07
Debt-to-Equity
06/30/25 - 0.02
03/31/25 - 0.03
12/31/24 - 0.03
Debt-to-Capital
06/30/25 - 1.85
03/31/25 - 3.37
12/31/24 - 3.21
 

Powered by Zacks Investment Research ©